The Liver Meeting 2022
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Contains (25)
Basic Debrief
Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture
Hepatitis B SIG Program: Navigating HBV treatment and cure by starting or stopping nucleos(t)ide analogues (NUC)
Hepatitis Debrief
Leon Schiff State-of-the-Art Lecture
Liver Cancer SIG and Pediatric Liver Disorders SIG Program: Pediatric Liver Cancers: From Mechanisms to Treatment. PART 1: Mechanisms of Tumorigenesis
NAFLD Debrief
Hans Popper State-of-the-Art Lecture
Liver Cancer SIG and Pediatric Liver Disorders SIG Program: Pediatric Liver Cancers: From Mechanisms to Treatment. PART 2: Improving Treatment
Portal Hypertension Debrief
Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture
Alcohol-associated Liver Disease SIG and Nonalcoholic Fatty Liver Disease SIG Program: NAFLD and ALD: Similarities, Differences, and Learning Opportunities. PART 1: Mechanisms, Risk Factors and Biomarkers
Alcohol-associated Liver Disease SIG and Nonalcoholic Fatty Liver Disease SIG Program: NAFLD and ALD: Similarities, Differences, and Learning Objectives: Targets, Treatments and Outcomes. PART 2
ACLF SIG and Clinical Practice SIG Program: State of the Art Management of Acute‐on‐Chronic Liver Failure. PART 1
ACLF SIG and Clinical Practice SIG Program: State of the Art Management of Acute‐on‐Chronic Liver Failure. PART 2
Public Health/ Health Care Delivery SIG Program: Dissemination and Implementation Research: Conceptual Framework and Applications in Hepatology
Pediatric Liver Disorders SIG Program: The Many Faces of Wilson Disease and Emerging Therapies
Hepatotoxicity SIG Program: Gut Microbiota and Drug-Induced Liver Injury-Basic Mechanisms and Clinical Applications
Hepatology Associates SIG Program: Surgical Risk Stratification in Patients with Cirrhosis
Cholestatic & Autoimmune Liver Diseases SIG and Liver Transplant & Surgery SIG Program: Optimizing Pre- and Post-Transplant Management of Immune Mediated Liver Disease. PART 1: Pre-Transplant Management of Immune Mediated Liver Disease
Cholestatic & Autoimmune Liver Diseases SIG and Liver Transplant & Surgery SIG Program: Optimizing Pre- and Post-Transplant Management of Immune Mediated Liver Disease. PART 2
Portal Hypertension SIG Program: Microbiota, Cirrhosis and Portal Hypertension
Liver Fibrosis SIG Liver Cell Biology SIG Program: Metabolic Reprogramming of Liver Cells as a Driving Force in Liver Fibrosis. PART 1
Liver Fibrosis SIG and Liver Cell Biology SIG Program: Metabolic Reprogramming of Liver Cells as a Driving Force in Liver Fibrosis. PART 2
Hepatitis C SIG Program: Remaining Challenges and Opportunities in Hepatitis C Prevention and Treatment

On-demand presentations from The Liver Meeting® 2022. The Liver Meeting® is AASLD’s largest meeting covering a variety of trending topics. Click Go To Search above to select the sessions you want to review. Choices include:

TLM 2022 - Debriefs
A series of debriefs covering leading topics from abstracts presented at The Liver Meeting 2022 in Washington, D.C.

Topics include:
  • Basic Science
  • Hepatitis
  • NAFLD
  • Portal Hypertension

TLM 2022 - State-of-the-Art Lectures
A collection of lectures covering the state of the art in liver medicine, originally presented at The Liver Meeting 2022 in Washington, D.C.

Lectures include: 
  • Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture, Normothermic Liver Perfusion to Improve Early Allograft Function
  • Leon Schiff State-of-the-Art Lecture, The evolution of disease modeling in NAFLD
  • Hans Popper State-of-the-Art Lecture, Human Organoids Toward Precision Hepatology
  • Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture, Mechanisms of Drug-induced Liver Injury

TLM 2022 - SIG Programming
Programming from TLM 2022 hosted by AASLD's Special Interest Groups

Programs include:
  • ACLF and Clinical Practice
  • ALD and NAFLD
  • Applications in Public Health
  • Cholestatic & Autoimmune and Liver Transplant
  • Hepatitis B
  • Hepatitis C
  • Hepatology Associates
  • Hepatotoxicity
  • Liver Cancer and Pediatrics
  • Liver Fibrosis
  • Pediatric Liver Disorders
  • Portal Hypertension
Powered By